Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need
- PMID: 39006382
- PMCID: PMC11238672
- DOI: 10.3748/wjg.v30.i25.3143
Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need
Abstract
In this editorial we comment on the article titled "Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease" by Zeng et al published in a recent issue of the World Journal of Gastroenterology. Non-alcoholic fatty liver disease (NAFLD) represents one of the current challenges in hepatology and public health, due to its continuous growing prevalence and the rising incidence of NAFLD-related fibrosis, non-alcoholic steatohepatitis and cirrhosis. The only effective therapeutic strategy for this disease is represented by encouraging patients to improve their lifestyle through the modification of dietary intake and increased physical exercise, but the effective application of such modifications is often limited by various factors such as lack of information, psychological barriers or poor social support. While poor adherence to a healthy lifestyle can be decisive in determining the clinical outcome, in daily practice there is a lack of quantitative instruments aimed at identifying patients with the lowest adherence to lifestyle changes and higher risk of disease progression in the course of follow-up. In this article, Zeng et al propose a quantitative scale to assess the grade of adherence of patients with NAFLD to healthy lifestyle intervention, called the Exercise and Diet Adherence Scale (EDAS). This scale, consisting of 33 items divided into 6 dimensions which relates to six subjective aspects in the self-management of NAFLD, has shown a good correlation with the identification of the sub-cohort of patients with the highest reduction in caloric intake, increase in physical exercise, probability of a reduction in liver stiffness measurement and alanine aminotransferase levels. The correlation among clinical outcomes and specific dimensions of this scale also highlights the pivotal role of a good and confidential doctor-patient relationship and of an effective communication. There is an urgent need for practical and effective instruments to assess the grade of self-management of NAFLD patients, together with the development of multidisciplinary teams with the aim of applying structured behavioral interventions.
Keywords: Insulin resistance; Liver cirrhosis; Metabolic associated fatty liver disease; Metabolic associated steatohepatitis; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Patient education; Self-management; Self-management measurement.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors have no conflicts of interest to disclose regarding this paper.
Similar articles
-
Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease.World J Gastroenterol. 2024 May 28;30(20):2629-2632. doi: 10.3748/wjg.v30.i20.2629. World J Gastroenterol. 2024. PMID: 38855158 Free PMC article.
-
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease.World J Gastroenterol. 2024 Mar 14;30(10):1393-1404. doi: 10.3748/wjg.v30.i10.1393. World J Gastroenterol. 2024. PMID: 38596499 Free PMC article.
-
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.World J Gastroenterol. 2024 May 28;30(20):2633-2637. doi: 10.3748/wjg.v30.i20.2633. World J Gastroenterol. 2024. PMID: 38855152 Free PMC article.
-
Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.Curr Vasc Pharmacol. 2018;16(3):239-245. doi: 10.2174/1570161115666170621080835. Curr Vasc Pharmacol. 2018. PMID: 28637408 Review.
-
Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity.Korean J Intern Med. 2018 Jan;33(1):64-74. doi: 10.3904/kjim.2017.343. Epub 2017 Dec 6. Korean J Intern Med. 2018. PMID: 29202557 Free PMC article. Review.
References
-
- Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516–537. - PubMed
-
- Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7:851–861. - PubMed
-
- Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V MAESTRO-NASH Investigators. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024;390:497–509. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical